Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Physicians’ Education Resource® Collaborates With GETICA (Spanish Group of Immuno-Biological Therapeutics in Cancer) for the 2nd Annual European Congress on Immunotherapies in Cancer™

Physicians’ Education Resource
Posted on: 14 Aug 17

Physicians’ Education Resource®, LLC (PER®) is teaming up for the second time with GETICA (Spanish Group of Immuno-Biological Therapeutics in Cancer)for the 2nd Annual European Congress on Immunotherapies in Cancer™, on Sept. 22-23, at Crowne Plaza Barcelona – Fire Center in Barcelona, Spain, announced Phil Talamo, president of PER®.

“It’s an honor to team up for another year with GETICA, who has pioneered the research in the field of Immunotherapy and development advanced therapies in cancer,” said Talamo. “Through this partnership, we aim to bring together oncology experts and thought leaders, who will provide attendees with the opportunity to sharpen their skills.”

Established in 2014, GETICA is a nonprofit organization focusing on the development of immunological and advanced therapies in cancer and neoplastic pathologies. Additionally, the organization supports the training of researchers and clinicians in various areas of immune-biological therapies.

The 2nd Annual European Congress on Immunotherapies in Cancer™ is a two-day comprehensive and interactive program, which features renowned program chair, Antoni Ribas, M.D., Ph.D., professor of medicine, surgery, and molecular and medical pharmacology at David Geffen School of Medicine; and Roman Perez-Soler, M.D., chairman of department of oncology at Montefiore Medical Center and professor of medicine and molecular pharmacology, deputy cancer center director of Albert Einstein College of Medicine. The program will focus on immunotherapies and their application in cancer management. Additionally, the faculty will provide insight on recent clinical trials, scientific advances and emerging testing methods.

For more information and registration, visit http://www.gotoper.com/conferences/ECIC/meetings/2nd-annual-european-congress-on-immunotherapies-in-Cancer.

About PER®:

Since 1995, PER® has been the leading provider of live, online and print CME activities focusing on oncology and hematology by providing high-quality, evidence-based activities featuring leading experts who focus on the application of practice-changing advances. In 2017, PER® will develop and implement 21 historic annual legacy conferences in the Unites States and Europe, along with many world- renowned online learning formats. PER® is also the publisher of the monthly peer-reviewed American Journal of Hematology/Oncology® and is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER® is part of the Cranbury, New Jersey-based Michael J. Hennessy Associates Inc. family of businesses. Learn more at www.gotoper.com and http://www.mjhassoc.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170814005800/en/

Business Wire
www.businesswire.com

Last updated on: 14/08/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.